A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
ImmunityBio, Inc.
NuCana plc
Eli Lilly and Company
GlaxoSmithKline
Canadian Cancer Trials Group
Calithera Biosciences, Inc
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center